Why Minocycline is Helpful in Huntington’s Disease

Alarcon G S (1998) Minocycline for the treatment of rheumatoid arthritis . Rheum Dis Clin North Am 24: 489–499

Berger A (2000) Minocycline slows progress of Huntington’s disease in mice . BMJ 321: 70-70

Bonelli R M , Heuberger C , Reisecker F (2003) Minocycline for Huntington’s disease: an open label study . Neurology 60: 883–884

Chen M , Ona V O , Li M , Ferrante R J , Fink K B , Zhu S , Bian J , Guo L , Farrell L A , Hersch S M , Hobbs W , Vonsattel J P , Cha J H , Friedlander R M (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease . Nature Med 6: 797–801

Denovan-Wright E M , Devarajan S , Dursun S M , Robertson H A (2002) Maintained improvement with minocycline of a patient with advanced Huntington’s disease . J Psychopharmacol 16: 393–394

Langevitz P , Livneh A , Bank I , Pras M (2000) Benefits and risks of minocycline in rheumatoid arthritis . Drug Saf 22: 405–414

Ona V O , Li M , Vonsattel J P , Andrews L J , Khan S Q , Chung W M , Frey A S , Menon A S , Li X J , Stieg P E , Yuan J , Penney J B , Young A B , Cha J H , Friedlander R M (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease . Nature 399: 263–267

Patel K , Cheshire D , Vance A (1998) Oral and systemic effects of prolonged minocycline therapy . Br Dent J 185: 560–562

Tikka T M , Koistinaho J E (2001) Minocycline provides neuroprotection againstn-methyl-d-aspartate neurotoxicity by inhibiting microglia . J Immunol 166: 7527–7533

Yamamoto A , Lucas J J , Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease . Cell 101: 57–66

Yrjanheikki J , Tikka T , Keinanen R , Goldsteins G , Chan PH , Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window . Proc Natl Acad Sci U S A 96: 13496-13500